Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Impact of Medicare Part D on Racial and Ethnic Minorities.

Jamison JJ, Wang J, Surbhi S, Adams S, Solomon D, Hohmeier KC, McDonough S, Eoff JC 3rd.

Divers Equal Health Care. 2016;13(5):326-333. Epub 2016 Aug 23.

PMID:
28008353
2.

Disparities in Treatment and Service Utilization Among Hispanics and Non-Hispanic Whites with Bipolar Disorder.

Salcedo S, McMaster KJ, Johnson SL.

J Racial Ethn Health Disparities. 2016 Apr 29. [Epub ahead of print]

PMID:
27129856
3.

The effectiveness of a brief mind-body intervention for treating depression in community health center patients.

Miller KM, Chad-Friedman E, Haime V, Mehta DH, Lepoutre V, Gilburd D, Peltier-Saxe D, Lilley C, Benson H, Fricchione GL, Denninger JW, Yeung A.

Glob Adv Health Med. 2015 Mar;4(2):30-5. doi: 10.7453/gahmj.2014.074.

4.

Illicit and nonmedical drug use among Asian Americans, Native Hawaiians/Pacific Islanders, and mixed-race individuals.

Wu LT, Blazer DG, Swartz MS, Burchett B, Brady KT; NIDA AAPI Workgroup..

Drug Alcohol Depend. 2013 Dec 1;133(2):360-7. doi: 10.1016/j.drugalcdep.2013.06.008. Epub 2013 Jul 23.

5.

Are there racial disparities in psychotropic drug use and expenditures in a nationally representative sample of men in the United States? Evidence from the Medical Expenditure Panel Survey.

Pierre G, Thorpe RJ Jr, Dinwiddie GY, Gaskin DJ.

Am J Mens Health. 2014 Jan;8(1):82-90. doi: 10.1177/1557988313496564. Epub 2013 Jul 24.

6.

Disparity implications of the Medicare medication therapy management eligibility criteria: a literature review.

Munshi KD, Shih YC, Brown LM, Dagogo-Jack S, Wan JY, Wang J.

Expert Rev Pharmacoecon Outcomes Res. 2013 Apr;13(2):201-16. doi: 10.1586/erp.13.6. Review.

7.

Depression and undertreatment of depression: potential risks and outcomes in black patients with lung cancer.

Traeger L, Cannon S, Pirl WF, Park ER.

J Psychosoc Oncol. 2013;31(2):123-35. doi: 10.1080/07347332.2012.761320.

8.

Beverage consumption and individual-level associations in South Korea.

Han E, Kim TH, Powell LM.

BMC Public Health. 2013 Mar 6;13:195. doi: 10.1186/1471-2458-13-195.

9.

Racial and ethnic disparities in meeting Part D MTM eligibility criteria among the non-Medicare population.

Wang J, Brown LM, Hong SH.

J Am Pharm Assoc (2003). 2012 Sep-Oct;52(5):e87-96.

10.

Estimating the effects of immigration status on mental health care utilizations in the United States.

Chen J, Vargas-Bustamante A.

J Immigr Minor Health. 2011 Aug;13(4):671-80. doi: 10.1007/s10903-011-9445-x.

11.

Racial and ethnic disparities in pediatric mental health.

Alegria M, Vallas M, Pumariega AJ.

Child Adolesc Psychiatr Clin N Am. 2010 Oct;19(4):759-74. doi: 10.1016/j.chc.2010.07.001.

12.

Ethnic disparities in accessing treatment for depression and substance use disorders in an integrated health plan.

Satre DD, Campbell CI, Gordon NS, Weisner C.

Int J Psychiatry Med. 2010;40(1):57-76.

13.

Pharmacological treatment of Alzheimer's disease: effect of race and demographic variables.

Hernandez S, McClendon MJ, Zhou XH, Sachs M, Lerner AJ.

J Alzheimers Dis. 2010;19(2):665-72. doi: 10.3233/JAD-2010-1269.

14.

Racial and ethnic disparities in the treatment of a Medicaid population with schizophrenia.

Horvitz-Lennon M, McGuire TG, Alegria M, Frank RG.

Health Serv Res. 2009 Dec;44(6):2106-22. doi: 10.1111/j.1475-6773.2009.01041.x. Epub 2009 Sep 24.

15.

Race and ethnicity and rural mental health treatment.

Petterson S, Williams IC, Hauenstein EJ, Rovnyak V, Merwin E.

J Health Care Poor Underserved. 2009 Aug;20(3):662-77. doi: 10.1353/hpu.0.0186.

16.

Estimating ethnic differences in self-reported new use of antidepressant medications: results from the Multi-Ethnic Study of Atherosclerosis.

Delaney JA, Oddson BE, McClelland RL, Psaty BM.

Pharmacoepidemiol Drug Saf. 2009 Jul;18(7):545-53. doi: 10.1002/pds.1751.

17.

Capacity for delivering culturally competent mental health services in New Mexico: results of a statewide agency survey.

Semansky RM, Altschul D, Sommerfeld D, Hough R, Willging CE.

Adm Policy Ment Health. 2009 Sep;36(5):289-307. doi: 10.1007/s10488-009-0221-3. Epub 2009 Apr 16. Erratum in: Adm Policy Ment Health. 2009 Sep;36(5):358-60.

18.

Memantine and acetylcholinesterase inhibitor treatment in cases of CDR 0.5 or questionable impairment.

McClendon MJ, Hernandez S, Smyth KA, Lerner AJ.

J Alzheimers Dis. 2009;16(3):577-83. doi: 10.3233/JAD-2009-0994.

19.

A prospective investigation of suicide ideation, attempts, and use of mental health service among adolescents in substance abuse treatment.

Ramchand R, Griffin BA, Harris KM, McCaffrey DF, Morral AR.

Psychol Addict Behav. 2008 Dec;22(4):524-32. doi: 10.1037/a0012969.

20.

Differences in pharmaceutical consumption and expenses between immigrant and Spanish-born populations in Lleida, (Spain): a 6-months prospective observational study.

Rue M, Serna MC, Soler-Gonzalez J, Bosch A, Ruiz-Magaz MC, Galvan L.

BMC Health Serv Res. 2008 Feb 6;8:35. doi: 10.1186/1472-6963-8-35.

Supplemental Content

Support Center